logo

GYRE

Gyre Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
3.39 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is GYRE a Buy, Sell, or Hold?
  • Based on a composite score of 3.39/10, we rate GYRE as a Netural. Our analysis breaks down into 1.31/10 for Fundamentals, 4.58/10 for Technicals, and 3.84/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is GYRE fundamentally strong?
What is the current technical signals for GYRE?
What is the analyst consensus for GYRE?